Index of reports
> Cases with Neuroleptic Malignant Syndrome (96)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mirtazapine where reactions include neuroleptic malignant syndrome. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 96 Next >>
Possible Mirtazapine side effects in 49 year old male
Reported by a consumer/non-health professional from France on 2012-08-23
Patient: 49 year old male
Reactions: Cytolytic Hepatitis, Neuroleptic Malignant Syndrome, Drug Withdrawal Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abilify
Dosage: until jul12
Administration route: Oral
Indication: Schizophrenia
Alprazolam
Administration route: Oral
End date: 2012-07-01
Mianserin HCL
End date: 2012-07-01
Mirtazapine
Dosage: formulation: tabs
Administration route: Oral
Possible Mirtazapine side effects in 51 year old male
Reported by a pharmacist from United Kingdom on 2012-08-13
Patient: 51 year old male
Reactions: Encephalopathy, Encephalitis, Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Metformin Hydrochloride; Simvastatin; Glimepiride
Possible Mirtazapine side effects in
Reported by a pharmacist from Japan on 2012-08-10
Patient:
Reactions: Neuroleptic Malignant Syndrome
Drug(s) suspected as cause:
Mirtazapine
Possible Mirtazapine side effects in 51 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-09
Patient: 51 year old male
Reactions: Confusional State, Agitation, Blood Creatine Phosphokinase Increased, Encephalopathy, Encephalitis, Convulsion, Blood Lactic Acid Increased, CSF Protein Increased, Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Simvastatin; Glimepiride; Metformin Hydrochloride
Possible Mirtazapine side effects in 51 year old male
Reported by a pharmacist from United Kingdom on 2012-08-09
Patient: 51 year old male
Reactions: Agitation, Confusional State, Encephalitis, Encephalopathy, Convulsion, Blood Lactic Acid Increased, CSF Protein Increased, Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Glimepiride; Metformin Hydrochloride; Simvastatin
Possible Mirtazapine side effects in 51 year old male
Reported by a pharmacist on 2012-08-07
Patient: 51 year old male
Reactions: Confusional State, Agitation, Encephalitis, Encephalopathy, Neuroleptic Malignant Syndrome, Blood Lactic Acid Increased, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Glimepiride; Metfformin Hydrochloride; Simvastatin
Possible Mirtazapine side effects in 51 year old male
Reported by a pharmacist from United Kingdom on 2012-08-07
Patient: 51 year old male
Reactions: Agitation, Confusional State, Blood Creatine Phosphokinase Increased, Encephalitis, Encephalopathy, Convulsion, Blood Lactic Acid Increased, CSF Protein Increased, Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Metformin Hydrochloride; Simvastatin; Glimepiride
Possible Mirtazapine side effects in
Reported by a pharmacist from United Kingdom on 2012-08-03
Patient:
Reactions: Confusional State, Agitation, Blood Creatine Phosphokinase Increased, Encephalitis, Encephalopathy, Blood Lactic Acid Increased, Convulsion, CSF Protein Increased, Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Glimepiride; Simvastatin; Metformin Hydrochloride
Possible Mirtazapine side effects in male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-02
Patient: male
Reactions: Agitation, Confusional State, Encephalopathy, Encephalitis, Neuroleptic Malignant Syndrome, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Metformin Hydrochloride; Glimepiride; Simvastatin
Possible Mirtazapine side effects in 51 year old male
Reported by a pharmacist from United Kingdom on 2012-08-01
Patient: 51 year old male
Reactions: Agitation, Confusional State, Encephalopathy, Neuroleptic Malignant Syndrome, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Glimepiride; Metformin Hydrochloride; Simvastatin; Sertraline Hydrochloride
Possible Mirtazapine side effects in 51 year old male
Reported by a pharmacist on 2012-07-31
Patient: 51 year old male
Reactions: CSF Protein Increased, Encephalopathy, Encephalitis, Neuroleptic Malignant Syndrome, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Simvastatin; Glimepiride; Metfformin Hydrochloride
Possible Mirtazapine side effects in 51 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-24
Patient: 51 year old male
Reactions: Agitation, Confusional State, Blood Creatine Phosphokinase Increased, Encephalitis, Encephalopathy, Convulsion, Blood Lactic Acid Increased, CSF Protein Increased, Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Glimepiride; Simvastatin; Metformin Hydrochloride
Possible Mirtazapine side effects in
Reported by a pharmacist from United Kingdom on 2012-07-24
Patient:
Reactions: Agitation, Confusional State, Blood Creatine Phosphokinase Increased, Encephalopathy, Encephalitis, Convulsion, Blood Lactic Acid Increased, CSF Protein Increased, Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Glimepiride; Simvastatin; Metformin Hydrochloride
Possible Mirtazapine side effects in 51 year old male
Reported by a pharmacist from United Kingdom on 2012-07-23
Patient: 51 year old male
Reactions: Encephalitis, Encephalopathy, Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Metformin Hydrochloride; Simvastatin; Glimepiride
Possible Mirtazapine side effects in 51 year old male
Reported by a pharmacist on 2012-07-20
Patient: 51 year old male
Reactions: Agitation, Confusional State, Encephalopathy, Encephalitis, Neuroleptic Malignant Syndrome, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Glimepiride; Simvastatin; Metfformin Hydrochloride
Possible Mirtazapine side effects in 51 year old male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-19
Patient: 51 year old male
Reactions: Confusional State, Agitation, Encephalitis, Neuroleptic Malignant Syndrome, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Simvastatin; Metformin Hydrochloride; Glimepiride
Possible Mirtazapine side effects in 51 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-14
Patient: 51 year old male
Reactions: Confusional State, Agitation, Encephalopathy, Neuroleptic Malignant Syndrome, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Other drugs received by patient: Metformin Hydrochloride; Sertraline Hydrochloride; Simvastatin; Glimepiride
Possible Mirtazapine side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-06
Patient: female, weighing 103.0 kg (226.6 pounds)
Reactions: Osteosynthesis, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Overdose, Myoglobin Blood Increased, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Lithium Citrate
Dosage: 1+0+0+1.5 (6 millimoles)
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 80 mg
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam
Possible Mirtazapine side effects in 72 year old female
Reported by a physician from Denmark on 2012-07-05
Patient: 72 year old female
Reactions: Rhabdomyolysis, Post Procedural Complication, Lactic Acidosis, Constipation, Fall, Liver Disorder, Multi-Organ Failure, Dialysis, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Polydipsia, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Cardiac Enzymes Increased, Lacunar Infarction, Hypertension, Infarction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram Oxalate
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: 6 mmol;unk;po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg;bid;po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Alprazolam; Ferro Curetter; Kalimklorid; Centyl MED
Possible Mirtazapine side effects in female
Reported by a physician from Denmark on 2012-06-29
Patient: female
Reactions: Osteosynthesis, Humerus Fracture, Rhabdomyolysis, Dyspnoea, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Lacunar Infarction, Neuroleptic Malignant Syndrome, Hypertension, Cardiac Hypertrophy, Hepatic Cirrhosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: dose: 1+0+0+1.5, styrke: 6 mmol li+
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam
Possible Mirtazapine side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-28
Patient: female
Reactions: Humerus Fracture, Osteosynthesis, Dyspnoea, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Lacunar Infarction, Neuroleptic Malignant Syndrome, Hypertension, Cardiac Hypertrophy, Hepatic Cirrhosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg, daily
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: 6 mmol, unk
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, daily
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone HCL
Dosage: 40 mg, bid
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Centyl MED Kaliumklorid; Fragmin; Ferro Duretter; Amlodipine Actavis; Alprazolam
Possible Mirtazapine side effects in 72 year old female
Reported by a physician from Denmark on 2012-06-26
Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)
Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Lactic Acidosis, Fall, Organ Failure, Multi-Organ Failure, Hyperventilation, Renal Failure, Lacunar Infarction, Depressed Level of Consciousness, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram Oxalate
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Lithium Citrate
Dosage: po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg;bid;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Other drugs received by patient: K CL TAB; Ferro Duretter; Alprazolam
Possible Mirtazapine side effects in female
Reported by a physician from Denmark on 2012-06-22
Patient: female
Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Dyspnoea, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cipralex
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: dose: 1+0+0+1.5, styrke: 6 mmol li+
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam
Possible Mirtazapine side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-22
Patient: female
Reactions: Confusional State, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Hyperventilation, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Organ Failure, Renal Failure, Lacunar Infarction, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Escitalopram
Dosage: 30 mg, qd
Administration route: Oral
End date: 2011-10-23
Lithium Citrate
Administration route: Oral
End date: 2011-10-23
Lithium Citrate
Dosage: 1.5 df (in the evening)
Administration route: Oral
End date: 2011-10-23
Lithium Citrate
Dosage: 1 df (in the morning)
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, qd
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg, bid
Administration route: Oral
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg, bid
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Alprazolam; Alprazolam; Centyl MED Kaliumklorid; Ferro Duretter
Possible Mirtazapine side effects in 72 year old female
Reported by a physician from Denmark on 2012-06-22
Patient: 72 year old female
Reactions: Confusional State, Rhabdomyolysis, Post Procedural Complication, Lactic Acidosis, Pyrexia, Serotonin Syndrome, Constipation, Fall, Hyperventilation, Multi-Organ Failure, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, General Physical Health Deterioration, Organ Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension
Adverse event resulted in: death
Drug(s) suspected as cause:
Escitalopram Oxalate
Dosage: 30 mg, qd, po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: 6 mmol, po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, qd, po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, qd, po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg, bid, po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Alprazolam; Ferro Duretter; Centyl MED; Kaliumklorid
Possible Mirtazapine side effects in 72 year old female
Reported by a physician from Denmark on 2012-06-22
Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)
Reactions: Confusional State, Osteosynthesis, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension, Infarction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg, daily
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, daily
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg, 2x/day
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Centyl K; Ferro Duretter; Alprazolam
Possible Mirtazapine side effects in 72 year old female
Reported by a physician from Denmark on 2012-06-19
Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)
Reactions: Rhabdomyolysis, Serotonin Syndrome, Lactic Acidosis, Constipation, Fall, Dialysis, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Cardiac Enzymes Increased, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Lacunar Infarction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram Oxalate
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Lithium Citrate
Dosage: po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg;bid;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Other drugs received by patient: Ferro Duretter; Alprazolam; K CL TAB
Possible Mirtazapine side effects in female
Reported by a physician from Denmark on 2012-06-15
Patient: female
Reactions: Confusional State, Rhabdomyolysis, Pyrexia, Lactic Acidosis, Constipation, Fall, Hyperventilation, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Organ Failure, Renal Failure, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: 1 df (in the morning)
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: 1.5 df (in the evening)
Administration route: Oral
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, qd
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: styrke: 40 mg
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Alprazolam; Ferro Duretter; Centyl MED Kaliumklorid
Possible Mirtazapine side effects in 72 year old female
Reported by a physician from Denmark on 2012-06-11
Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)
Reactions: Osteosynthesis, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension, Infarction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg, daily
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, daily
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg, 2x/day
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Alprazolam; Fragmin; Ferro Duretter; Amlodipine; Centyl K; Furosemide
Possible Mirtazapine side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) on 2012-06-06
Patient: 44 year old female
Reactions: Bedridden, Confusional State, Psychomotor Retardation, Hyperthermia, Nuchal Rigidity, Serotonin Syndrome, Muscle Rigidity, Hyperhidrosis, Loss of Consciousness, Neuroleptic Malignant Syndrome, Blood Pressure Fluctuation, Hypertonia, Mobility Decreased
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Mirtazapine
Dosage: 180 mg (45 mg, 4 in 1 d), oral
Administration route: Oral
Indication: Depression
Start date: 2008-01-23
End date: 2008-02-12
Risperidone
Dosage: (62.5 mg, 1 wk)
Indication: Bipolar Disorder
Start date: 2007-11-02
End date: 2008-01-24
Page 1 Next >>
|